Corporate Governance25 Mar 2026, 12:00 pm
Nectar Lifesciences Ltd Announces Trading Window Closure
AI Summary
Nectar Lifesciences Ltd, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct, has announced the closure of the trading window for designated persons and their immediate relatives. The closure will be effective from April 01, 2026, until 48 hours after the declaration of Financial Results for the period ending on March 31, 2026. Designated Persons and their immediate relatives are advised not to trade in the securities of the Company during this period.
Key Highlights
- Nectar Lifesciences Ltd announces trading window closure for designated persons and their immediate relatives.
- The closure is pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct.
- The closure will be effective from April 01, 2026, until 48 hours after the declaration of Financial Results for the period ending on March 31, 2026.
- Designated Persons and their immediate relatives are advised not to trade in the securities of the Company during this period.
- The Stock Exchanges have been informed about the closure.
Price Impact
More from NECLIFE